NCT06905119 Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
| NCT ID | NCT06905119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Miguel Servet |
| Condition | Infusions, Intravenous |
| Study Type | INTERVENTIONAL |
| Enrollment | 201 participants |
| Start Date | 2023-05-04 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 201 participants in total. It began in 2023-05-04 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study focuses on patients who require outpatient infusion of therapy ("Infusions, Intravenous"\[Mesh\]) "Administration, Intravenous"\[Mesh\] ("Home Infusion Therapy"\[Mesh\]) "Parenteral Nutrition, Home"\[Mesh\] via a peripherally inserted central catheter (PICC) ("Central Venous Catheters"\[MeSH\] "Catheterization, Central Venous"\[MeSH\] "Catheterization, Peripheral" \[MeSH\] "Vascular Access Devices"\[Mesh\] )
Eligibility Criteria
Inclusion Criteria: * Patients \>18 years. * Sign the informed consent form. * Have a Smartphone and accept the use of the APP. * Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month. Exclusion Criteria: * Patients with limitations in the use of digital resources or lack of Smartphone. * Patients who do not want to install the APP on their Smartphone * Patients who do not authorize access to their Computerized Medical Record (HCI).
Contact & Investigator
María Inés Corcuera Martínez MI Corcuera Martínez, RN-PhD(c)
✉ mi.corcuera.martinez@navarra.es📞 +34 687609658
Frequently Asked Questions
Who can join the NCT06905119 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infusions, Intravenous. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06905119 currently recruiting?
Yes, NCT06905119 is actively recruiting participants. Contact the research team at mi.corcuera.martinez@navarra.es for enrollment information.
Where is the NCT06905119 trial being conducted?
This trial is being conducted at Pamplona, Spain.
Who is sponsoring the NCT06905119 clinical trial?
NCT06905119 is sponsored by Fundacion Miguel Servet. The trial plans to enroll 201 participants.